262 related articles for article (PubMed ID: 24016602)
1. A mutation associated with centronuclear myopathy enhances the size and stability of dynamin 2 complexes in cells.
James NG; Digman MA; Ross JA; Barylko B; Wang L; Li J; Chen Y; Mueller JD; Gratton E; Albanesi JP; Jameson DM
Biochim Biophys Acta; 2014 Jan; 1840(1):315-21. PubMed ID: 24016602
[TBL] [Abstract][Full Text] [Related]
2. Dynamin-2 mutations associated with centronuclear myopathy are hypermorphic and lead to T-tubule fragmentation.
Chin YH; Lee A; Kan HW; Laiman J; Chuang MC; Hsieh ST; Liu YW
Hum Mol Genet; 2015 Oct; 24(19):5542-54. PubMed ID: 26199319
[TBL] [Abstract][Full Text] [Related]
3. Common membrane trafficking defects of disease-associated dynamin 2 mutations.
Liu YW; Lukiyanchuk V; Schmid SL
Traffic; 2011 Nov; 12(11):1620-33. PubMed ID: 21762456
[TBL] [Abstract][Full Text] [Related]
4. Mild functional differences of dynamin 2 mutations associated to centronuclear myopathy and Charcot-Marie Tooth peripheral neuropathy.
Koutsopoulos OS; Koch C; Tosch V; Böhm J; North KN; Laporte J
PLoS One; 2011; 6(11):e27498. PubMed ID: 22096584
[TBL] [Abstract][Full Text] [Related]
5. Dynamin 2 mutants linked to centronuclear myopathies form abnormally stable polymers.
Wang L; Barylko B; Byers C; Ross JA; Jameson DM; Albanesi JP
J Biol Chem; 2010 Jul; 285(30):22753-7. PubMed ID: 20529869
[TBL] [Abstract][Full Text] [Related]
6. Dynamin-2 mutations linked to Centronuclear Myopathy impair actin-dependent trafficking in muscle cells.
González-Jamett AM; Baez-Matus X; Olivares MJ; Hinostroza F; Guerra-Fernández MJ; Vasquez-Navarrete J; Bui MT; Guicheney P; Romero NB; Bevilacqua JA; Bitoun M; Caviedes P; Cárdenas AM
Sci Rep; 2017 Jul; 7(1):4580. PubMed ID: 28676641
[TBL] [Abstract][Full Text] [Related]
7. Correlative SICM-FCM reveals changes in morphology and kinetics of endocytic pits induced by disease-associated mutations in dynamin.
Ali T; Bednarska J; Vassilopoulos S; Tran M; Diakonov IA; Ziyadeh-Isleem A; Guicheney P; Gorelik J; Korchev YE; Reilly MM; Bitoun M; Shevchuk A
FASEB J; 2019 Jul; 33(7):8504-8518. PubMed ID: 31017801
[TBL] [Abstract][Full Text] [Related]
8. Different in vivo impacts of dynamin 2 mutations implicated in Charcot-Marie-Tooth neuropathy or centronuclear myopathy.
Massana Muñoz X; Buono S; Koebel P; Laporte J; Cowling BS
Hum Mol Genet; 2019 Dec; 28(24):4067-4077. PubMed ID: 31628461
[TBL] [Abstract][Full Text] [Related]
9. A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice.
Durieux AC; Vignaud A; Prudhon B; Viou MT; Beuvin M; Vassilopoulos S; Fraysse B; Ferry A; Lainé J; Romero NB; Guicheney P; Bitoun M
Hum Mol Genet; 2010 Dec; 19(24):4820-36. PubMed ID: 20858595
[TBL] [Abstract][Full Text] [Related]
10. Mutant BIN1-Dynamin 2 complexes dysregulate membrane remodeling in the pathogenesis of centronuclear myopathy.
Fujise K; Okubo M; Abe T; Yamada H; Nishino I; Noguchi S; Takei K; Takeda T
J Biol Chem; 2021; 296():100077. PubMed ID: 33187981
[TBL] [Abstract][Full Text] [Related]
11. A noncanonical role for dynamin-1 in regulating early stages of clathrin-mediated endocytosis in non-neuronal cells.
Srinivasan S; Burckhardt CJ; Bhave M; Chen Z; Chen PH; Wang X; Danuser G; Schmid SL
PLoS Biol; 2018 Apr; 16(4):e2005377. PubMed ID: 29668686
[TBL] [Abstract][Full Text] [Related]
12. Dynamin 2 mutations associated with human diseases impair clathrin-mediated receptor endocytosis.
Bitoun M; Durieux AC; Prudhon B; Bevilacqua JA; Herledan A; Sakanyan V; Urtizberea A; Cartier L; Romero NB; Guicheney P
Hum Mutat; 2009 Oct; 30(10):1419-27. PubMed ID: 19623537
[TBL] [Abstract][Full Text] [Related]
13. Regulation of dynamin-2 assembly-disassembly and function through the SH3A domain of intersectin-1s.
Knezevic I; Predescu D; Bardita C; Wang M; Sharma T; Keith B; Neamu R; Malik AB; Predescu S
J Cell Mol Med; 2011 Nov; 15(11):2364-76. PubMed ID: 21129155
[TBL] [Abstract][Full Text] [Related]
14. Centronuclear Myopathy Caused by Defective Membrane Remodelling of Dynamin 2 and BIN1 Variants.
Fujise K; Noguchi S; Takeda T
Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682949
[TBL] [Abstract][Full Text] [Related]
15. Oligomerization state of dynamin 2 in cell membranes using TIRF and number and brightness analysis.
Ross JA; Digman MA; Wang L; Gratton E; Albanesi JP; Jameson DM
Biophys J; 2011 Feb; 100(3):L15-L17. PubMed ID: 21281565
[TBL] [Abstract][Full Text] [Related]
16. Structural insights into the centronuclear myopathy-associated functions of BIN1 and dynamin 2.
Hohendahl A; Roux A; Galli V
J Struct Biol; 2016 Oct; 196(1):37-47. PubMed ID: 27343996
[TBL] [Abstract][Full Text] [Related]
17. Dynamin GTPase regulation is altered by PH domain mutations found in centronuclear myopathy patients.
Kenniston JA; Lemmon MA
EMBO J; 2010 Sep; 29(18):3054-67. PubMed ID: 20700106
[TBL] [Abstract][Full Text] [Related]
18. A centronuclear myopathy-causing mutation in dynamin-2 disrupts neuronal morphology and excitatory synaptic transmission in a murine model of the disease.
Arriagada-Diaz J; Flores-Muñoz C; Gómez-Soto B; Labraña-Allende M; Mattar-Araos M; Prado-Vega L; Hinostroza F; Gajardo I; Guerra-Fernández MJ; Bevilacqua JA; Cárdenas AM; Bitoun M; Ardiles AO; Gonzalez-Jamett AM
Neuropathol Appl Neurobiol; 2023 Aug; 49(4):e12918. PubMed ID: 37317811
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological features of centronuclear myopathy in Japanese populations harboring mutations in dynamin 2.
Mori-Yoshimura M; Okuma A; Oya Y; Fujimura-Kiyono C; Nakajima H; Matsuura K; Takemura A; Malicdan MC; Hayashi YK; Nonaka I; Murata M; Nishino I
Clin Neurol Neurosurg; 2012 Jul; 114(6):678-83. PubMed ID: 22613877
[TBL] [Abstract][Full Text] [Related]
20. Dynamin-2 mediates clathrin-dependent endocytosis for amyloid-β internalization in brain microvascular endothelial cells.
Du SS; Sun X; Cen J; Shi JX; An MX; Zhao WD
Microvasc Res; 2021 Nov; 138():104219. PubMed ID: 34214572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
